N-(3,5-dichloro-4-(3-isopropyl-4-methoxyphenoxy)phenyl)-2-(pyridin-4-yl)acetamide

ID: ALA4783024

Chembl Id: CHEMBL4783024

PubChem CID: 155781898

Max Phase: Preclinical

Molecular Formula: C23H22Cl2N2O3

Molecular Weight: 445.35

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Oc2c(Cl)cc(NC(=O)Cc3ccncc3)cc2Cl)cc1C(C)C

Standard InChI:  InChI=1S/C23H22Cl2N2O3/c1-14(2)18-13-17(4-5-21(18)29-3)30-23-19(24)11-16(12-20(23)25)27-22(28)10-15-6-8-26-9-7-15/h4-9,11-14H,10H2,1-3H3,(H,27,28)

Standard InChI Key:  NPIGEOLECVWXHK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4783024

    ---

Associated Targets(Human)

RORC Tchem Nuclear receptor ROR-gamma (8495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THRB Tclin Thyroid hormone receptor beta-1 (7926 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC-38 (857 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.35Molecular Weight (Monoisotopic): 444.1007AlogP: 6.49#Rotatable Bonds: 7
Polar Surface Area: 60.45Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.75CX Basic pKa: 5.04CX LogP: 5.62CX LogD: 5.62
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.45Np Likeness Score: -1.12

References

1. Ruan Z,Park PK,Wei D,Purandare A,Wan H,O'Malley D,Stachura S,Perez H,Cavallaro CL,Weigelt CA,Sack JS,Ruzanov M,Khan J,Gururajan M,Wong JJ,Huang Y,Yarde M,Li Z,Chen C,Sun H,Borowski V,Xie JH,Anthony M,Agler M,Fink BE,Harikrishnan LS.  (2021)  Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonists.,  35  [PMID:33422603] [10.1016/j.bmcl.2021.127778]

Source